Brian Lian
2019
In 2019, Brian Lian earned a total compensation of $3.5M as Chief Executive Officer at Viking Therapeutics, a 150% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $210,000 |
|---|---|
| Option Awards | $1,246,740 |
| Salary | $525,000 |
| Stock Awards | $1,530,379 |
| Total | $3,512,119 |
Lian received $1.5M in stock awards, accounting for 44% of the total pay in 2019.
Lian also received $210K in non-equity incentive plan, $1.2M in option awards and $525K in salary.
Rankings
In 2019, Brian Lian's compensation ranked 3,455th out of 13,971 executives tracked by ExecPay. In other words, Lian earned more than 75.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,455 out of 13,971 | 75th |
Division Manufacturing | 1,254 out of 5,695 | 78th |
Major group Chemicals And Allied Products | 431 out of 2,194 | 80th |
Industry group Drugs | 359 out of 1,880 | 81st |
Industry Pharmaceutical Preparations | 270 out of 1,392 | 81st |
Source: SEC filing on April 6, 2020.
Lian's colleagues
We found one more compensation record of an executive who worked with Brian Lian at Viking Therapeutics in 2019.
2019
Hiroko Masamune
Viking Therapeutics
Former Chief Development Officer
News
Viking Therapeutics CEO Brian Lian's 2021 pay falls 22% to $4.1M
April 7, 2022
Viking Therapeutics CEO Brian Lian's 2020 pay jumps 48% to $5.2M
April 8, 2021
Viking Therapeutics CEO Brian Lian's 2019 pay jumps 150% to $3.5M
April 6, 2020
Viking Therapeutics CEO Brian Lian's 2018 pay jumps 74% to $1.4M
April 5, 2019